• Pitavastatin (NK-104): Practical Guide for In Vitro Use

  2026-07-31

  Pitavastatin (NK-104, SKU B1124) is a potent HMG-CoA reductase inhibitor designed for in vitro blockade of cholesterol biosynthesis, with applications in cardiovascular and atherosclerosis research. It is optimized for cellular and biochemical assays, particularly those investigating mitophagy activation and the CAMK1-PINK1 pathway. This product is not validated for use in clinical or animal models and should only be employed under defined laboratory conditions.

• Deep Learning Uncovers Cardiotoxicity in iPSC-CM Screens

  2026-07-30

  This study pioneers the integration of deep learning with high-content phenotypic screening in human iPSC-derived cardiomyocytes to rapidly detect drug-induced cardiotoxicity. Its scalable approach offers a promising framework for early de-risking in drug discovery and enhances the predictive value of in vitro cardiac safety assessments.

• Octenidine dihydrochloride: Optimizing Laboratory Antiseptic

  2026-07-30

  Octenidine dihydrochloride enables reproducible, high-precision research into microbial membrane disruption and antiseptic action. Discover advanced protocol enhancements, troubleshooting strategies, and comparative insights informed by the latest gemini quaternary ammonium compound research.

• Decoding Apoptosis: Advanced Insights with One-step TUNEL Cy

  2026-07-29

  Explore how the One-step TUNEL Cy3 Apoptosis Detection Kit revolutionizes apoptosis research through precise detection of DNA fragmentation. This article unveils scientific nuances, protocol parameters, and practical assay implications not addressed elsewhere.

• Firefly Luciferase mRNA (5-moUTP): Mechanism, Evidence & Use

  2026-07-29

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) is a high-stability, low-immunogenicity reporter mRNA optimized for robust bioluminescent assays. This 5-moUTP modified mRNA enables efficient translation and durable protein expression, supporting advanced mRNA delivery and translation efficiency assays.

• Grazoprevir/Elbasvir: Innovations in HCV Genotype 1 and 4 Th

  2026-07-28

  The reference study systematically evaluates the efficacy and safety of the fixed-dose combination of Grazoprevir (MK-5172 hydrate) and Elbasvir for hepatitis C virus (HCV) infection, emphasizing its high sustained virologic response rates across genotypes 1 and 4 and favorable outcomes for complex patient populations. The findings inform clinical protocols and translational research on direct-acting antiviral regimens for HCV.

• Anti Reverse Cap Analog: Advancing Synthetic mRNA Translatio

  2026-07-28

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, is redefining synthetic mRNA research by doubling translational efficiency and enhancing mRNA stability. This thought-leadership article explores the mechanistic rationale, experimental validation, and strategic implementation of ARCA in translational workflows, while contextualizing recent mitochondrial proteostasis findings for next-generation mRNA applications.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Protocol Power

  2026-07-27

  The One-step TUNEL Cy3 Apoptosis Detection Kit empowers researchers to uncover nuanced apoptotic events in both tissue sections and cultured cells, combining speed, sensitivity, and reproducibility. Its streamlined workflow and robust Cy3 fluorescence set a new standard for DNA fragmentation assays in apoptosis research.

• CX-5461 as an RNA Polymerase I Inhibitor in Cancer Research

  2026-07-27

  CX-5461 provides a unique mechanism for targeting ribosome biogenesis in solid tumors, offering researchers a potent tool for inducing cellular senescence and autophagy rather than apoptosis. Its synergy with cisplatin and ability to overcome chemoresistance position it as a game-changer in advanced cancer model workflows.

• Rottlerin as a PKCδ Inhibitor: Mechanistic Insights for Tran

  2026-07-26

  Discover how Rottlerin, a selective PKC inhibitor, uniquely modulates cell signaling and viral entry. This article offers deeper mechanistic insights and cross-domain perspectives for advanced research applications.

• Sex Differences in Cannabinoid Withdrawal Behaviors in Rats

  2026-07-25

  This study systematically dissects the somatic and anxiety-like withdrawal behaviors in male and female rats following chronic exposure to the synthetic cannabinoid agonist WIN 55,212-2, using Rimonabant (SR141716) to precipitate withdrawal. The findings reveal qualitative sex differences in withdrawal expression, informing translational models of cannabinoid dependence and highlighting the nuanced impact of endocannabinoid system modulators.

• BI 2536: Protocol Optimization for PLK1 Inhibitor Assays

  2026-07-24

  BI 2536, a gold-standard PLK1 inhibitor from APExBIO, empowers researchers to dissect mitotic checkpoint control and apoptosis in cancer models. This guide bridges experimental design, protocol refinement, and troubleshooting with data-driven insights for reliable cell cycle arrest and tumor research.

• Polybrene (Hexadimethrine Bromide): Advanced Transduction Wo

  2026-07-24

  Polybrene (Hexadimethrine Bromide) stands apart as a viral attachment facilitator and transfection enhancer, enabling robust and reproducible gene delivery even in challenging cell types. This guide details actionable workflows, troubleshooting tips, and best-in-class protocol enhancements, drawing on recent innovations and quantitative insights.

• Precision Antisepsis in Chromatin and Stem Cell Research

  2026-07-23

  Explore how Ethacridine lactate monohydrate empowers translational researchers to achieve contamination-free, high-fidelity chromatin and stem cell assays. This thought-leadership article blends mechanistic insight into microbial growth inhibition with strategic guidance for safeguarding experimental reproducibility—bridging super-enhancer biology, YAP-TEAD networks, and next-generation antiseptic strategies.

• Cholesterol Impedes LNP Trafficking: Insights from Biotin-St

  2026-07-23

  This study introduces a sensitive biotin–streptavidin-based tracking platform to reveal how cholesterol content in lipid nanoparticles (LNPs) disrupts their intracellular trafficking and diminishes nucleic acid delivery. The findings highlight cholesterol’s specific role in trapping LNPs in peripheral endosomes, providing actionable guidance for LNP optimization in gene delivery applications.

16443 records 1/1097 page Next 12345 下5页 Last page